Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Teva Recalling Parkinson’s Drug Batch in US

carbidopa-levodopa

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has recalled a batch of its generic Parkinson’s combination drug treatment carbidopa/levodopa because of concern that it may contain too much active pharmaceutical ingredient.

The company said that the Class II recall involved 3, 881 bottles of 25 or 100mg carbidopa/levodopa. Teva added that stability testing found that the product might be “superpotent.” The voluntary recall is for the entire US.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.

A class II recall as defined by the US Food and Drug Administration (FDA) means that use of a drug could cause temporary damage to health.

Published by Globes [online], Israel business news – www.globes-online.com – on August 28, 2014

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Copyright © 2021 Jewish Business News